0
0
The European Medicines Agency (EMA) has approved booster vaccinations against coronavirus using the U.S. company Moderna’s Spikevax vaccine.
“Data showed that a third dose of Spikevax given six to eight months after the second dose resulted in an increase in antibody levels in adults whose antibody levels had decreased,” the Amsterdam-based agency said Monday, explaining its decision.
Third Corona vaccination with Moderna approved in EU
Competent health authorities in EU countries could now make official recommendations for the administration of booster doses “taking into account the local epidemiological situation,” the EMA further explained.
Side effects similar to first vaccinations
According to the data, side effects of booster vaccinations with the Moderna drug have so far been similar to those observed after two vaccinations. “The risk of inflammatory heart disease and other very rare side effects after a booster is carefully monitored,” the EMA added.
Earlier in October, the agency had given a general green light to booster vaccinations with the Biontech vaccine for adults for the first time. At the same time, the agency had initially recommended an extra dose of Moderna only for people with severely weakened immune systems.
—source: vienna.at/picture:pixabay.at
This post has already been read 471 times!
